ESC 365 - Evidence-based novel therapies in HCM

Open Access

Evidence-based novel therapies in HCM

Session: Staging therapy in hypertrophic cardiomyopathy patients with heart failure: new insights

Topic: Hypertrophic Cardiomyopathy

Speaker: Doctor M. Michels (Rotterdam, NL)

Sponsored by PACE-CME - Supported by an unrestricted educational grant from Bristol Myers Squibb

Event: Heart Failure 2024

Congress Presentation

Add to my library

About the speaker

Doctor Michelle Michels

Erasmus University Medical Centre, Rotterdam (Netherlands (The))

13 presentations

4 followers

4 more presentations in this session

Welcome and introduction

Speaker: Professor P. Seferovic (Belgrade, RS)

Recognition and diagnosing heart failure in patients with HCM

Speaker: Professor A. Linhart (Prague, CZ)

Optimal pharmacological management of HCM by clinical manifestations

Speaker: Doctor P. Garcia-Pavia (Majadahonda, ES)

Panel discussion and Q&A

Speaker: Professor P. Seferovic (Belgrade, RS)

Access the full session

Staging therapy in hypertrophic cardiomyopathy patients with heart failure: new insights

Speakers: Doctor M. Michels, Professor P. Seferovic, Professor A. Linhart, Doctor P. Garcia-Pavia, Professor P. Seferovic

About the event

Heart Failure 2024

11 May - 14 May 2024

Sessions Presentations

Congress

ESC 365 is supported by

bristol-myers-squibb

Explore sponsored resources

novartis

Explore sponsored resources

novo-nordisk

Explore sponsored resources